CALCIBET ointment

CALCIBET ointment is a combination medication containing two active ingredients: calcipotriol and betamethasone. Calcipotriol is a synthetic form of vitamin D3, while betamethasone is a corticosteroid. This ointment is used topically to treat psoriasis, a chronic autoimmune skin condition characterized by inflamed, red, and scaly patches on the skin. Calcipotriol works by slowing down the rapid growth of skin cells and reducing inflammation, while betamethasone helps to alleviate itching, redness, and swelling associated with psoriatic lesions.

Key Features:

• Treatment of Psoriasis: CALCIBET ointment is indicated for the topical treatment of psoriasis vulgaris, a common form of psoriasis, in adults.
• Combination Therapy: The combination of calcipotriol and betamethasone in CALCIBET ointment provides a synergistic effect, leading to improved efficacy in the management of psoriasis symptoms.
• Dual Action: Calcipotriol acts as a vitamin D3 analog, regulating skin cell growth and differentiation, while betamethasone acts as a potent corticosteroid, reducing inflammation and immune responses.
• Topical Application: CALCIBET ointment is applied directly to affected areas of the skin, usually once daily. It should be gently rubbed into the skin until fully absorbed.
• Gradual Improvement: Improvement in psoriasis symptoms may be seen within a few weeks of starting treatment with CALCIBET ointment, but optimal results may take several weeks of continuous use.

Uses:

CALCIBET ointment is used for the topical treatment of psoriasis vulgaris in adults. It helps to reduce the symptoms of psoriasis, including redness, scaling, itching, and inflammation, by normalizing skin cell growth and reducing immune-mediated responses.

Dosage and Administration:

• Apply a thin layer of CALCIBET ointment to the affected areas of the skin once daily.
• Gently rub the ointment into the skin until fully absorbed.
• Wash hands after applying the ointment, unless the hands are the treated area.
• Avoid using CALCIBET ointment on the face, groin, or underarms unless directed by a healthcare provider.
• Treatment duration may vary depending on the severity of psoriasis and individual response to therapy.

Precautions:

• CALCIBET ointment is for external use only. Avoid contact with eyes, mouth, or mucous membranes.
• Do not apply CALCIBET ointment to broken or infected skin unless directed by a healthcare provider.
• Long-term use of corticosteroids like betamethasone may cause skin thinning, so it should be used cautiously, especially on sensitive areas of the skin.
• Consult a healthcare provider before using CALCIBET ointment if pregnant, breastfeeding, or planning pregnancy.

Side Effects:

Common side effects of CALCIBET ointment may include skin irritation, burning sensation, itching, redness, or dryness at the application site. Rarely, prolonged use of corticosteroids may lead to skin thinning, stretch marks, or changes in skin pigmentation.

Frequently Asked Questions (FAQs):

1. Can CALCIBET ointment be used on the face? CALCIBET ointment is not recommended for use on the face, groin, or underarms unless directed by a healthcare provider, as these areas are more sensitive to the effects of corticosteroids.
2. How long does it take for CALCIBET ointment to work? Improvement in psoriasis symptoms may be seen within a few weeks of starting treatment with CALCIBET ointment, but optimal results may take several weeks of continuous use.
3. Can CALCIBET ointment be used during pregnancy? Pregnant or breastfeeding women should consult a healthcare provider before using CALCIBET ointment, as safety during pregnancy and lactation has not been established.
4. What should I do if I miss a dose of CALCIBET ointment? If a dose of CALCIBET ointment is missed, it should be applied as soon as possible. However, if it is almost time for the next dose, the missed dose should be skipped, and the regular dosing schedule resumed.
5. Can CALCIBET ointment be used in children? The safety and efficacy of CALCIBET ointment in pediatric patients have not been established, and its use in children should be guided by a healthcare provider based